Who did the buying? Market cap is up $15m or so from the $5m sale price. What were the losses like from those assets for them to say the sale is EPS accretive? Were any small holders convinced to buy from this or is it institutional buying?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025